Immunology / Virology & Vaccines

Doctor prepares vaccine
#Clinical trials #Immunology / Virology & Vaccines #Marburg virus #Vaccine candidate #World Health Organization

Vaccine trials to start in response to Marburg virus outbreak

Rwanda will start clinical trials of experimental vaccines and treatments for Marburg virus in the next few weeks, its health minister announced following news of an outbreak in the country. Marburg virus disease is highly virulent and causes haemorrhagic fever, with a fatality ratio of up… Read More

#News #Trending News

Vaccine
#Clinical trials #Drug development #Funding #Immunology / Virology & Vaccines #Respiratory #Vicebio

New financing and clinical trial for RSV/hMOV bivalent vaccine

Vicebio has announced a $100 million Series B financing, which will be used to develop next-generation vaccines for respiratory viruses.   The development will utilise Vicebio’s Molecular Clamp technology, discovered at The University of Queensland. The technology stabilises viral glycoproteins in their highly immunogenic ‘prefusion’ conformation, crucial for… Read More

#News

#Advanced Therapies #Immunology / Virology & Vaccines

Webinar: Quantitative analysis of full and empty particles in adeno-associated virus vectors for gene therapy – supported by Thermo Fisher Scientific 05.09.2024

In this webinar, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presents his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy.  In recent years, AAV vectors have been launched and are considered one of the main platforms for gene therapy, with more than 250 clinical… Read More

#Webinars

#BioNTech #Cancer immunotherapy #Cancer vaccine #European Commission #Immunology / Virology & Vaccines #mRNA #University College London Hospitals

First patient dosed in UK novel cancer vaccine trial

A lung cancer patient at University College London Hospitals (UCLH) is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.  It is the first time this immunotherapy made by BioNTech will be studied in a clinical… Read More

#Cancer Research #News

Zika virus
#Antivirals #Immunology / Virology & Vaccines #Juntendo University #Proteins

New understanding of Flaviviruses suggests novel treatment strategies

Researchers have uncovered how Flaviviruses like Dengue and Zika propagate, suggesting the possibility of new treatment strategies. They have identified a transporter protein, called importin-7 (IPO7), as crucial for the nuclear transport of Flaviviridae core proteins. Viruses of the family Flaviviridae, including Japanese encephalitis… Read More

#News

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Older adult receiving vaccine
#Dementia #Immunology / Virology & Vaccines #Neurodegenerative disorders #Neuroscience #Shingles #University of Oxford

New shingles vaccine found to reduce risk of dementia

New evidence indicates that a new shingles vaccine is more protective against dementia compared to the previous shingles vaccine, which was also reported to reduce dementia rates. It is also more protective than vaccines against other infections. A study of more… Read More

#News

Colourised scanning electron micrograph of Marburg virus particles
#Clinical trial #Immunology / Virology & Vaccines #University of Oxford #Vaccine candidate

First-in-human vaccine trial for deadly Marburg virus

Scientists at the University of Oxford in the UK have launched a new clinical trial to test a vaccine to protect against “devastating” Marburg virus. This is the first-in-human trial of the ChAdOx1 Marburg vaccine, which has been developed and manufactured by researchers at the University… Read More

#News #Trending News

#Drug discovery #Immunology / Virology & Vaccines

Webinar: Innovative strategies for residual DNA and viral titre quantitation using dPCR – supported by Thermo Fisher Scientific 20.06.2024

Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets.  In… Read More

#Webinars

#AI / data analytics / healthtech / informatics #Anti-inflammatory #Artificial intelligence (AI) #Cancer research #Covid-19 #EpicentRx #Immunology / Virology & Vaccines #Oncology #Polypharmacologic #Precision medicine #Protein binders #Therapeutic targets

New podcast on the significance of drug repurposing

This is the latest episode of the free DDW narrated podcast, titled “Why drug repurposing is so significant for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI use in repurposing drugs for Covid-19 and RRx-001: Jack… Read More

#News

Close up of vaccine syringe
#Covid-19 #Covid-19 vaccine #Flu vaccine #Immunology / Virology & Vaccines #Influenza #Moderna

Combination vaccine better than separate flu and Covid-19 jabs

In clinical trials, Moderna’s combination vaccine elicited higher immune responses against influenza (flu) virus and SARS-CoV-2 than licensed flu and Covid-19 vaccines in adults 50 years and older. The Phase III trial investigated mRNA-1083, an investigational combination vaccine against influenza and Covid-19. mRNA-1083 comprises… Read More

#News #Trending News

#FDA #Immunology / Virology & Vaccines #Moderna #mRNA #mRNA-based vaccines #Respiratory syncytial virus

US approves first mRNA vaccine since Covid-19

The US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a breakthrough therapy designation and marks… Read More

#News #Regulatory

Vaccine
#Clinical trial #Immunology / Virology & Vaccines #Interview #University of Oxford #Vaccines

Vaccines and various response rates

DDW Editor Reece Armstrong speaks to Dr Katrina Pollock from the Oxford Vaccine Group at the University of Oxford. Dr Pollock is the Chief Investigator of the LEGACY03 clinical trial, a study aiming to investigate lymph nodes and vaccination responses across age groups. RA: Could you tell us about the… Read More

#Exclusive Content

#Coronavirus #Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #Pandemic prevention #University of Cambridge

‘Proactive’ vaccine protects against unknown future coronaviruses

Researchers have developed a new vaccine technology that can provide protection against a broad range of coronaviruses with potential for future disease outbreaks – including ones we don’t know about yet. This approach to vaccine development is called ‘proactive vaccinology’, where scientists build a vaccine before… Read More

#Editor's Choice #News

Vaccine
#Immunology / Virology & Vaccines #Interview #Structural biology #Vaccines

How structural biology is informing vaccine design

Reece Armstrong speaks to Melanie Adams-Cioaba, Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. RA: How can rational design approaches help advance vaccine development?     MA: Regarding vaccine development specifically, and the role my team plays in the development of… Read More

#Exclusive Content

Covid-19
#Covid-19 #Immunity #Immunology / Virology & Vaccines #University of Oxford

Study proves value of infection studies in developing new vaccines

A study led by the University of Oxford has successfully investigated human immunity against Covid-19 in people who already have antibodies, with the aim of advancing future vaccines and treatments. The results suggest that previous infection, together with vaccination, offers strong protection against the original Covid-19… Read More

#News